ARTICLE | Clinical News
Revlimid lenalidomide regulatory update
August 30, 2010 7:00 AM UTC
Celgene said FDA noted that its Office of Generic Drugs has received an ANDA containing a Paragraph IV certification for a generic lenalidomide. Celgene said that once it has receiveed official notifi...